
Viracta and Burgeon Brewing Company
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode of The Biotech and Breweries Podcast, Noah Scoville, Manager at Burgeon Brewing, shares four beers from the craft beer brewery: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press.
Dan Chevallard, COO and Chief Financial Officer of Viracta shares his journey with Viracta and their pursuit of EBV-associated cancers with a combination drug product. He discusses the evolution of Viracta as a company, their targeted approach to merging oncology with virology, and how to fundraise with a bridge mentality and not a pyramid mentality.
Quotes:
“Community is such a core thing for us and making great beer is a huge thing as well. Without good beer, especially in San Diego with 160 different breweries, you’re kind of gonna get drowned out. There is a lot of noise. So you’ve got to have great beer to separate yourself from the others.” - Noah Scoville [03:38]
“For an individual who is trying to start a company: have a mentor. You have to have someone you can talk to that’s seen it, done and that you can bounce ideas off of. Operating in a silo is not ideal.” - Dan Chevallard [34:01]
Topics discussed:
- Burgeon Beer
- Brews: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press
- Dan’s journey in BioScience
- Viracta’s progress
- The intersection of Oncology and Virology
- Accessing the public market
- Dan’s fundraising advice
Resources:
Connect with Viracta:
Website
Connect with Burgeon Brewing:
Website
SUBSCRIBE: Subscribe to the podcast to make sure you never miss an episode.